Q2 2023 · 13F-HR
Logos Global Management LPholdings as filed
Filed 2023-08-14 · accession 0001172661-23-003013
$735.2M
Reported value
51
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $56.9M | 7.74% | 625,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $53.8M | 7.32% | 1,650,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $42.7M | 5.81% | 2,250,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $41.1M | 5.59% | 1,750,000 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $34.4M | 4.67% | 300,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $33.8M | 4.60% | 3,743,875 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $30.0M | 4.08% | 500,000 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $28.5M | 3.87% | 100,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $28.3M | 3.85% | 300,000 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $26.8M | 3.64% | 1,125,000 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $24.3M | 3.30% | 520,000 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $22.9M | 3.11% | 5,250,000 | Common | SOLE |
| 45114M109 | — | ICOSAVAX INC | $21.5M | 2.93% | 2,165,741 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $20.0M | 2.72% | 1,780,000 | Common | SOLE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $17.6M | 2.40% | 2,797,501 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $16.6M | 2.26% | 400,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $15.8M | 2.15% | 500,000 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $15.2M | 2.07% | 750,000 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $13.3M | 1.80% | 520,000 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $12.3M | 1.68% | 3,500,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $11.2M | 1.52% | 650,000 | CALL | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $10.6M | 1.44% | 275,000 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $10.2M | 1.38% | 250,000 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $9.5M | 1.29% | 800,000 | Common | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $9.2M | 1.25% | 2,800,000 | Common | SOLE |
| 617760202 | MOR2 | MORPHOSYS AG | $9.0M | 1.22% | 1,200,000 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $8.7M | 1.18% | 100,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $8.2M | 1.12% | 250,000 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $7.8M | 1.06% | 650,000 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $7.6M | 1.03% | 35,000 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $7.5M | 1.02% | 1,000,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $7.1M | 0.96% | 2,200,000 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $6.9M | 0.93% | 1,178,787 | Common | SOLE |
| 38406L103 | — | GRACELL BIOTECHNOLOGIES INC | $6.9M | 0.93% | 1,800,000 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $6.3M | 0.85% | 307,076 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $5.8M | 0.78% | 500,000 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $5.7M | 0.78% | 525,000 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $5.4M | 0.74% | 525,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $5.3M | 0.72% | 500,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $5.2M | 0.70% | 300,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $5.0M | 0.68% | 250,000 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $4.9M | 0.67% | 200,000 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $4.5M | 0.62% | 544,960 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $3.5M | 0.48% | 600,000 | Common | SOLE |
| 23306J101 | — | DBV TECHNOLOGIES S A | $2.3M | 0.31% | 1,200,000 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $1.8M | 0.24% | 188,390 | Common | SOLE |
| 00773J103 | — | AEGLEA BIOTHERAPEUTICS INC | $1.4M | 0.19% | 3,142,880 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $1.1M | 0.14% | 421,184 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $638,400 | 0.09% | 280,000 | Common | SOLE |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $542,780 | 0.07% | 31,872 | Common | SOLE |
| 67080N119 | NUVB/WS | NUVATION BIO INC | $11,027 | 0.00% | 66,666 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.